Aurobindo Pharma Limited
-
{
- All
- News
-
CSIR Collaborates With Aurobindo Pharma To Develop COVID-19 Vaccines
The Council of Scientific and Industrial Research (CSIR) and Aurobindo Pharma Limited on Tuesday announced a collaboration to develop vaccines for COVID-19.
-
Aurobindo Gets USFDA Nod for Esomol Hydrochloride Injection
It is indicated for the short-term treatment of tachycardia and hypertension that occur during induction and tracheal intubation, during surgery, on emergence from anaesthesia and in the postoperative period, it said.
-
Aurobindo Pharma to Raise $350 Million Through QIP
The board had earlier constituted a securities issue committee comprising of five board members, including two independent directors, for issue of securities.
-
Aurobindo Pharma May Spend Rs 1,300 Crore Towards Capex in FY15-16
The capex will be spread out across APIs (active pharmaceutical ingredients) and formulations and the company's operations have resulted in substantial improvement to support the capex through internal cash generation, he said.
-
Aurobindo Pharma Limited - Allotment of Securities
Aurobindo Pharma Ltd has informed the Exchange that regarding allotment of shares on Conversion of FCCBs.
-
CSIR Collaborates With Aurobindo Pharma To Develop COVID-19 Vaccines
The Council of Scientific and Industrial Research (CSIR) and Aurobindo Pharma Limited on Tuesday announced a collaboration to develop vaccines for COVID-19.
-
Aurobindo Gets USFDA Nod for Esomol Hydrochloride Injection
It is indicated for the short-term treatment of tachycardia and hypertension that occur during induction and tracheal intubation, during surgery, on emergence from anaesthesia and in the postoperative period, it said.
-
Aurobindo Pharma to Raise $350 Million Through QIP
The board had earlier constituted a securities issue committee comprising of five board members, including two independent directors, for issue of securities.
-
Aurobindo Pharma May Spend Rs 1,300 Crore Towards Capex in FY15-16
The capex will be spread out across APIs (active pharmaceutical ingredients) and formulations and the company's operations have resulted in substantial improvement to support the capex through internal cash generation, he said.
-
Aurobindo Pharma Limited - Allotment of Securities
Aurobindo Pharma Ltd has informed the Exchange that regarding allotment of shares on Conversion of FCCBs.
